RxDoctor Payments Data

Trenton Bowen, MD

Glaucoma Specialist · Gilbert, AZNPI 1609220979

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Glaukos Corporation at 27.6% of the total. 2025 is the largest year on record at $1,176, more than ten times the $81 reported in 2020.

$3,871in general payments, 2019–2025

Across 136 payments — averaging $28.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Glaukos Corporation$1K
  • Alcon$1K
  • Bausch & Lomb Americas Inc.$276
  • AbbVie$258
  • Sight Sciences, Inc.$217
  • NEW World Medical,inc.$214
  • plus $778 from 12 others

What the payments were for

  • Food & beverage$3,871100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few glaucoma specialist providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$543,815
Medicare patients
965
Services billed
4,973

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost124$70,557
RestasisCyclosporine64$56,804
RocklatanNetarsudil Mesylat/Latanoprost66$44,530
Prednisolone Acetate467$28,512
Dorzolamide-TimololDorzolamide/Timolol/Pf158$22,694
Cyclosporine35$16,941
CombiganBrimonidine Tartrate/Timolol27$13,227
VyzultaLatanoprostene Bunod22$12,412
XiidraLifitegrast16$12,061
Timolol MaleateTimolol Maleate/Pf23$10,293
RhopressaNetarsudil Mesylate16$9,400
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat501$8,956
Latanoprost853$8,746
MoxifloxacinMoxifloxacin Hcl400$7,972
SimbrinzaBrinzolamide/Brimonidine Tart38$7,853

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Restasis, Combigan, Alphagan P$258$147,958227 claims
Bausch & Lomb Americas Inc.Vyzulta, Xiidra$276$24,47338 claims
AlconSimbrinza$1,058$7,85338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few glaucoma specialist providers in Arizonaon file to place this against a meaningful peer group, so we don't.

Other glaucoma specialist in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →